Please provide your email address to receive an email when new articles are posted on . Compared with atorvastatin, rosuvastatin is associated with increased risks of hematuria, proteinuria and kidney ...

Althera announced the FDA approved its rosuvastatin/ezetimibe tablets as an adjunct to diet for treatment of elevated LDL in adults with primary nonfamilial hyperlipidemia or homozygous familial ...

Few real-world studies have investigated the risks of hematuria and proteinuria associated with rosuvastatin use. Rosuvastatin may increase the risk of hematuria, proteinuria, and kidney failure, ...

A head-to-head comparison of two popular lipid-lowering medications suggests that rosuvastatin may be a better option than atorvastatin when it comes to decreasing the risk of all-cause mortality and ...

A 76-year-old Filipina woman who had been taking rosuvastatin 40 mg per day without a problem for more than 5 years started developing pain and weakness in her thighs just days after starting on the ...